# Phase 22.7 - Portfolio + Strategy Operations Credibility

Date: 2026-05-23

Final status: **PENDING PRODUCTION VALIDATION**

## Scope

Phase 22.7 hardens the paper portfolio and Strategy Labs operating layer so the product exposes evidence-backed lifecycle, allocation, drawdown, revision, autopsy, and risk operations without inventing broker state, fills, returns, or institutional compliance workflows.

Implemented:

- Position lifecycle cards now expose thesis, entry reason, stop/target, invalidation, open drawdown, exit plan, and lesson state.
- Thesis lifecycle cards now include explicit lifecycle stage labels: created, revised, weakened, invalidated, or closed.
- Allocation history now shows current/prior allocation context, rebalance rationale, and risk-change narrative from stored paper account/event evidence.
- Drawdown stories now show drawdown start/period, cause, macro/risk context, recovery status, and lesson.
- Strategy revisions now show what changed, why it changed, confidence before/after when stored, and evidence basis.
- Trade autopsies now disclose whether they are replay-backed, setup-context only, or no-replay, and explicitly avoid fake broker-fill claims.
- Portfolio risk operations remain tied to concentration, sector, macro, liquidity, correlation, shock, and scenario-stress evidence from the portfolio intelligence layer.
- A visible operations proof-gate panel now summarizes pass/partial/fail status for lifecycle, thesis, allocation/rebalance, drawdown, revisions, autopsies, and risk operations.

## Files Changed

- `frontend/src/lib/trading/institutional-portfolio-operations.ts`
- `frontend/src/components/paper/InstitutionalPortfolioOperationsPanel.tsx`
- `frontend/src/lib/trading/institutional-portfolio-operations.test.ts`

## Trust Boundaries

- Paper operations use stored paper rows and event ledgers only; they do not claim broker execution.
- Strategy Labs operations use completed simulation evidence only; they do not claim live portfolio management.
- Replay-backed autopsies are marked only when Strategy Labs completed replay/simulation context exists.
- Paper autopsies disclose when they are setup-context only or have no replay evidence.
- Confidence before/after is shown as "Not stored" unless persisted evidence exists.
- The phase does not implement broker account linking, real fills, external account statements, or institutional compliance approval flows.

## Local Validation

Completed:

- `npm --prefix frontend run lint` passed.
- `npm --prefix frontend test -- --runInBand` passed, 483 tests.
- `npm --prefix frontend run build` passed.
- `npm --prefix frontend audit --omit=dev` passed, 0 vulnerabilities.
- `python3 -m py_compile $(git ls-files '*.py')` passed.
- `npx pyright . --pythonpath .venv/bin/python --warnings` passed, 0 errors and 0 warnings.
- `git diff --check` passed.

Targeted test coverage:

- `frontend/src/lib/trading/institutional-portfolio-operations.test.ts` now asserts lifecycle completeness, allocation rationale/risk change, thesis lifecycle stage labeling, drawdown context, replay-boundary disclosures, strategy revision evidence basis, and proof-gate status.

## Production Evidence

Pending:

- Commit and push to `main`
- Production pull on `sre@100.68.155.121`
- Frontend rebuild/redeploy
- Production health smoke
- Production route smoke for `/paper` and `/strategy-labs`

## Remaining Blockers

Pending final validation. Known product-boundary blockers remain:

- No broker-backed fills.
- No external account statements.
- No compliance approval workflow.
- No real institutional operations evidence beyond paper and Strategy Labs operating data.

## Verdict

PENDING
